GlycoMimetics
GlycoMimetics, Inc., a biopharmaceutical company, engages in the design and development of small molecule therapeutics to mimic the functions of bioactive carbohydrates. Its products include GMI-1070, a synthetic glycomimetic molecule designed to...Founded in 2003
Homepage: http://www.glycomimetics.com/
Total money raised: $38M
20878
101 Orchard Ridge Drive
Suite 1E
Gaithersburg
USA MD
Suite 1E
Gaithersburg
USA MD
Phone: 240-243-1201
Updated on Dec 7, 2009
GlycoMimetics at CrunchBase
Rachel K. King Founder, CEOGlycoMimetics at CrunchBase
John Magnani Chief Scientific Officer and Vice President
Past
December, 2009
GlycoMimetics raised $38M in a Series C round from New Enterprise Associates, Novartis Venture Fund, Anthem Capital Management, Alliance Technology Ventures, and Genzyme Ventures
GlycoMimetics, Inc.: Series C $38M 
onbiovc.com
2003
GlycoMimetics was founded in 2003